All articles tagged with #chs
A study of cannabis hyperemesis syndrome (CHS) involving over 1,100 respondents found heavy daily use of THC-rich vape cartridges was linked to a faster onset of CHS symptoms, including the severe vomiting nicknamed “scromiting,” compared with smoking or edibles; researchers caution that the results show association, not causation, and CHS remains poorly understood with limited treatment options.
Cannabinoid hyperemesis syndrome (CHS), also known as 'scromiting,' is a rare but increasingly recognized condition among long-term high-potency cannabis users, characterized by severe vomiting and abdominal pain. Its prevalence has risen significantly with increased legalization and potency of cannabis, especially among young adults. Experts suggest moderation and further research into the condition's causes and mechanisms, as abstinence remains the only confirmed treatment.
A rare condition called Cannabis Hyperemesis Syndrome (CHS), also known as 'scromiting', is increasingly reported among frequent marijuana users, especially teenagers, causing severe stomach pain, nausea, and vomiting, with unclear triggers and no established guidelines on usage levels that cause it.
A former weed addict discusses cannabinoid hyperemesis syndrome (CHS), a severe condition caused by chronic cannabis use that leads to intense vomiting ('scromiting') and can cause permanent health issues like osteoporosis, emphasizing the importance of complete abstinence and seeking professional help for addiction recovery.
Scromiting, medically known as cannabinoid hyperemesis syndrome (CHS), is a severe condition linked to long-term cannabis use that causes intense nausea and vomiting, leading to increased ER visits. Recognized by WHO and CDC, its prevalence is rising as cannabis consumption becomes more frequent, highlighting the need for medical awareness and patient education.
A study finds that emergency room visits for cannabinoid hyperemesis syndrome (CHS), a severe vomiting condition linked to long-term cannabis use, have increased in the US, especially during the COVID-19 pandemic, highlighting the need for greater awareness and research on this rare but serious side effect.
A woman experienced severe vomiting and pain due to cannabinoid hyperemesis syndrome (CHS), a condition linked to heavy marijuana use, which can only be cured by quitting cannabis.
Cannabinoid hyperemesis syndrome (CHS) is a rare condition that causes bouts of vomiting and abdominal pain in people who use high doses of marijuana daily over an extended period of time. CHS is often overlooked or misdiagnosed due to a lack of tests for diagnosis and the misperception that marijuana use can help with nausea and vomiting. Stopping marijuana use is the most successful way to manage the condition. If you believe that you may be suffering from CHS, talk to a doctor to seek medical attention.
Cannabinoid hyperemesis syndrome (CHS) is a rare condition that causes bouts of vomiting and abdominal pain, which affects people who use high doses of marijuana daily over an extended period of time. CHS is often overlooked or misdiagnosed due to a lack of tests for diagnosis and patients' misperception that marijuana is helping them. Stopping marijuana use is the most successful way to manage the condition. If you believe that you may be suffering from CHS, talk to a doctor to seek medical attention.
Chronic cannabis use can lead to Cannabis Hyperemesis Syndrome (CHS), a condition characterized by cyclic vomiting and abdominal pain, which can cause dehydration, electrolyte imbalances, and renal failure, increasing the risk of nephrolithiasis or kidney stones. A recent case study highlights that CHS should be considered in chronic cannabis users with multiple episodes of vomiting and abdominal pain. Treatment for CHS includes IV fluid replacement, symptomatic management, and rehabilitation, with options like benzodiazepines, antiepileptics, and antipsychotics. The prevention of recurrent renal stones in CHS involves abstinence and adequate hydration. Healthcare professionals should monitor chronic cannabis users for potential complications.